Genocea Biosciences' IPO

Genocea Biosciences raised a round of funding on February 05, 2014. Investors include Public.

Genocea Biosciences is harnessing the power of T cell immunity to develop the next generation of vaccines. The company is working to create vaccines that stimulate the T cell arm of the immune system,…

Articles about Genocea Biosciences' IPO: